Ausgabe 2/2020
Inhalt (25 Artikel)
- editorial
Circumnavigating the challenges of COVID-19 in oncology
Thorsten Fuereder, Eberhard Gunsilius, Rupert Bartsch, Wolfgang Hilbe
- Open Access
- short review
ESMO 2019—personal non-small lung cancer highlights
Lena Horvath, Andreas Pircher
- Open Access
- short review
The role of surgery in soft tissue sarcoma: Can we improve outcome and function towards sporting activities?
Reinhard Windhager, Gerhard M. Hobusch
- short review
Metastatic sarcoma: tailored strategies for a heterogeneous disease
Massimiliano Grassi, Andrea Spagnoletti, Alberto Puccini
- Open Access
- short review
Screening for ovarian cancer: is there still hope?
Stefanie Aust, Veronika Seebacher-Shariat
- Open Access
- short review
Ovarian cancer surgery
Richard Schwameis, Valentina Paspalj, Marlene Kranawetter, Stephan Polterauer
- Open Access
- review
PARP inhibitors in the treatment of ovarian cancer
Alain G. Zeimet, Verena Wieser, Katharina Knoll, Daniel Reimer, Christian Marth
- Open Access
- short review
Current state and perspectives of checkpoint inhibitors in ovarian cancer treatment
Thomas Bartl, Valentina Paspalj, Stephan Polterauer, Christoph Grimm
- Open Access
- short review
Thermal ablation—an option in curative treatment of HCC
Daniel Putzer, Peter Schullian, Gernot Eberle, Reto Josef Bale
- Open Access
- review
The intestinal microbiota and hepatocellular carcinoma
Maria Effenberger, Herbert Tilg
- Open Access
- original report
PLATON: use of romiplostim to treat chronic primary immune thrombocytopenia
Georgi Mihaylov, Barbara Skopec, Zuzana Sninska, Nikolai Tzvetkov, Olga Cerna, Vladlen Ivanushkin, Daniela Niepel, Katja Björklöf, Peter Černelč
- original report
Different CALR mutation subtypes in essential thrombocythemia and primary myelofibrosis patients without JAK2 mutation
Layla M. Saleh, Reem Algamal, Hanaa Abd Elmasseh, Emily Barber, Hasan Abdel-ghaffar
